| Year |
Citation |
Score |
| 2024 |
Herold KC, Delong T, Perdigoto AL, Biru N, Brusko TM, Walker LSK. The immunology of type 1 diabetes. Nature Reviews. Immunology. PMID 38308004 DOI: 10.1038/s41577-023-00985-4 |
0.367 |
|
| 2023 |
Foster TP, Jacobsen LM, Bruggeman B, Salmon C, Hosford J, Chen A, Cintron M, Mathews CE, Wasserfall C, Brusko MA, Brusko TM, Atkinson MA, Schatz DA, Haller MJ. Low-Dose Antithymocyte Globulin: A Pragmatic Approach to Treating Stage 2 Type 1 Diabetes. Diabetes Care. PMID 38117469 DOI: 10.2337/dc23-1750 |
0.417 |
|
| 2023 |
Chen J, Liu C, Chernatynskaya AV, Newby B, Brusko TM, Xu Y, Barra JM, Morgan N, Santarlas C, Reeves WH, Tse HM, Leiding JW, Mathews CE. NADPH Oxidase 2-Derived Reactive Oxygen Species Promote CD8+ T Cell Effector Function. Journal of Immunology (Baltimore, Md. : 1950). PMID 38079221 DOI: 10.4049/jimmunol.2200691 |
0.365 |
|
| 2023 |
Redondo MJ, Harrall KK, Glueck DH, Tosur M, Uysal S, Muir A, Atkinson EG, Shapiro MR, Yu L, Winter WE, Weedon M, Brusko TM, Oram R, Vehik K, Hagopian W, et al. Diabetes Study of Children of Diverse Ethnicity and Race: Study design. Diabetes/Metabolism Research and Reviews. e3744. PMID 37888801 DOI: 10.1002/dmrr.3744 |
0.454 |
|
| 2023 |
Thirawatananond P, Brown ME, Sachs LK, Arnoletti JM, Yeh WI, Posgai AL, Shapiro MR, Chen YG, Brusko TM. Treg-specific CD226 Deletion Reduces Diabetes Incidence in NOD Mice by Improving Regulatory T Cell Stability. Diabetes. PMID 37625150 DOI: 10.2337/db23-0307 |
0.406 |
|
| 2023 |
Shapiro MR, Dong X, Perry DJ, McNichols JM, Thirawatananond P, Posgai AL, Peters LD, Motwani K, Musca RS, Muir A, Concannon P, Jacobsen LM, Mathews CE, Wasserfall CH, Haller MJ, ... ... Brusko TM, et al. Human immune phenotyping reveals accelerated aging in type 1 diabetes. Jci Insight. PMID 37498686 DOI: 10.1172/jci.insight.170767 |
0.478 |
|
| 2023 |
Matsumoto R, Gray J, Rybkina K, Oppenheimer H, Levy L, Friedman LM, Khamaisi M, Meng W, Rosenfeld AM, Guyer RS, Bradley MC, Chen D, Atkinson MA, Brusko TM, Brusko M, et al. Induction of bronchus-associated lymphoid tissue is an early life adaptation for promoting human B cell immunity. Nature Immunology. PMID 37460638 DOI: 10.1038/s41590-023-01557-3 |
0.415 |
|
| 2023 |
Jacobsen LM, Diggins K, Blanchfield L, McNichols JA, Perry DJ, Brant J, Dong X, Bacher R, Gersuk VH, Schatz DA, Atkinson MA, Mathews CE, Haller MJ, Long SA, Linsley PS, ... Brusko TM, et al. Responders to low-dose ATG induce CD4 T cell exhaustion in type 1 diabetes. Jci Insight. PMID 37432736 DOI: 10.1172/jci.insight.161812 |
0.55 |
|
| 2023 |
Connors TJ, Matsumoto R, Verma S, Szabo PA, Guyer R, Gray J, Wang Z, Thapa P, Dogra P, Poon MML, Rybkina K, Bradley MC, Idzikowski E, McNichols J, Kubota M, ... ... Brusko TM, et al. Site-specific development and progressive maturation of human tissue-resident memory T cells over infancy and childhood. Immunity. PMID 37421943 DOI: 10.1016/j.immuni.2023.06.008 |
0.444 |
|
| 2023 |
Peters LD, Yeh WI, Arnoletti JM, Brown ME, Posgai AL, Mathews CE, Brusko TM. Modeling cell-mediated immunity in human type 1 diabetes by engineering autoreactive CD8 T cells. Frontiers in Immunology. 14: 1142648. PMID 37325626 DOI: 10.3389/fimmu.2023.1142648 |
0.44 |
|
| 2023 |
Becker MW, Peters LD, Myint T, Smurlick D, Powell A, Brusko TM, Phelps EA. Immune engineered extracellular vesicles to modulate T cell activation in the context of type 1 diabetes. Science Advances. 9: eadg1082. PMID 37267353 DOI: 10.1126/sciadv.adg1082 |
0.401 |
|
| 2023 |
Perry DJ, Shapiro MR, Chamberlain SW, Kusmartseva I, Chamala S, Balzano-Nogueira L, Yang M, Brant JO, Brusko M, Williams MD, McGrail KM, McNichols J, Peters LD, Posgai AL, Kaddis JS, ... ... Brusko TM, et al. A genomic data archive from the Network for Pancreatic Organ donors with Diabetes. Scientific Data. 10: 323. PMID 37237059 DOI: 10.1038/s41597-023-02244-6 |
0.47 |
|
| 2022 |
Redondo MJ, Richardson SJ, Perry D, Minard CG, Carr ALJ, Brusko T, Kusmartseva I, Pugliese A, Atkinson MA. Milder loss of insulin-containing islets in individuals with type 1 diabetes and type 2 diabetes-associated TCF7L2 genetic variants. Diabetologia. PMID 36282337 DOI: 10.1007/s00125-022-05818-y |
0.484 |
|
| 2022 |
Marshall GP, Cserny J, Wang CW, Looney B, Posgai AL, Bacher R, Keselowsky B, Brusko TM. Biomaterials-based nanoparticles conjugated to regulatory T cells provide a modular system for localized delivery of pharmacotherapeutic agents. Journal of Biomedical Materials Research. Part A. PMID 36082558 DOI: 10.1002/jbm.a.37442 |
0.304 |
|
| 2022 |
Brown ME, Peters LD, Hanbali SR, Arnoletti JM, Sachs LK, Nguyen KQ, Carpenter EB, Seay HR, Fuhrman CA, Posgai AL, Shapiro MR, Brusko TM. Human CD4CD25CD226 Tregs Demonstrate Increased Purity, Lineage Stability, and Suppressive Capacity Versus CD4CD25CD127 Tregs for Adoptive Cell Therapy. Frontiers in Immunology. 13: 873560. PMID 35693814 DOI: 10.3389/fimmu.2022.873560 |
0.376 |
|
| 2022 |
Kaddis JS, Perry DJ, Vu AN, Rich SS, Atkinson MA, Schatz DA, Roep BO, Brusko TM. Improving the Prediction of Type 1 Diabetes Across Ancestries. Diabetes Care. PMID 35043156 DOI: 10.2337/dc21-1254 |
0.447 |
|
| 2022 |
Yang JHM, Ward-Hartstonge KA, Perry DJ, Blanchfield JL, Posgai AL, Wiedeman AE, Diggins K, Rahman A, Tree TIM, Brusko TM, Levings MK, James EA, Kent SC, Speake C, Homann D, et al. Guidelines for standardizing T-cell cytometry assays to link biomarkers, mechanisms, and disease outcomes in type 1 diabetes. European Journal of Immunology. 52: 372-388. PMID 35025103 DOI: 10.1002/eji.202049067 |
0.333 |
|
| 2021 |
Missarova A, Jain J, Butler A, Ghazanfar S, Stuart T, Brusko M, Wasserfall C, Nick H, Brusko T, Atkinson M, Satija R, Marioni JC. geneBasis: an iterative approach for unsupervised selection of targeted gene panels from scRNA-seq. Genome Biology. 22: 333. PMID 34872616 DOI: 10.1186/s13059-021-02548-z |
0.38 |
|
| 2021 |
Armitage LH, Stimpson SE, Santostefano KE, Sui L, Ogundare S, Newby BN, Castro-Gutierrez R, Huber MK, Taylor JP, Sharma P, Radichev IA, Perry DJ, Fredette NC, Savinov AY, Wallet MA, ... ... Brusko TM, et al. Use of Induced Pluripotent Stem Cells to Build Isogenic Systems and Investigate Type 1 Diabetes. Frontiers in Endocrinology. 12: 737276. PMID 34858326 DOI: 10.3389/fendo.2021.737276 |
0.344 |
|
| 2021 |
Linsley PS, Barahmand-Pour-Whitman F, Balmas E, DeBerg HA, Flynn KJ, Hu AK, Rosasco MG, Chen J, O'Rourke C, Serti E, Gersuk VH, Motwani K, Seay HR, Brusko TM, Kwok WW, et al. Autoreactive T cell receptors with shared germline-like α chains in type 1 diabetes. Jci Insight. 6. PMID 34806648 DOI: 10.1172/jci.insight.151349 |
0.38 |
|
| 2021 |
Brusko TM, Mallone R, Rodriguez-Calvo T. Editorial: Footprints of Immune Cells in the Type 1 Diabetic Pancreas. Frontiers in Endocrinology. 12: 767012. PMID 34721308 DOI: 10.3389/fendo.2021.767012 |
0.339 |
|
| 2021 |
Vecchione A, Jofra T, Gerosa J, Shankwitz K, Di Fonte R, Galvani G, Ippolito E, Cicalese MP, Schultz AR, Seay HR, Favellato M, Milardi G, Stabilini A, Ragogna F, Grogan P, ... ... Brusko T, et al. Reduced Follicular Regulatory T Cells in Spleen and Pancreatic Lymph Nodes of Patients With Type 1 Diabetes. Diabetes. 70: 2892-2902. PMID 34620616 DOI: 10.2337/db21-0091 |
0.355 |
|
| 2021 |
Sharp RC, Brown ME, Shapiro MR, Posgai AL, Brusko TM. The Immunoregulatory Role of the Signal Regulatory Protein Family and CD47 Signaling Pathway in Type 1 Diabetes. Frontiers in Immunology. 12: 739048. PMID 34603322 DOI: 10.3389/fimmu.2021.739048 |
0.305 |
|
| 2021 |
Brusko TM, Russ HA, Stabler CL. Strategies for durable β cell replacement in type 1 diabetes. Science (New York, N.Y.). 373: 516-522. PMID 34326233 DOI: 10.1126/science.abh1657 |
0.305 |
|
| 2021 |
Perry DJ, Peters LD, Lakshmi PS, Zhang L, Han Z, Wasserfall CH, Mathews CE, Atkinson MA, Brusko TM. Overexpression of the Autoimmune Risk Variant LYP-620W Fails to Restrain Human CD4 T Cell Activation. Journal of Immunology (Baltimore, Md. : 1950). PMID 34301848 DOI: 10.4049/jimmunol.2000708 |
0.569 |
|
| 2021 |
Li W, Gong M, Park YP, Elshikha AS, Choi SC, Brown J, Kanda N, Yeh WI, Peters L, Titov AA, Teng X, Brusko TM, Morel L. Lupus susceptibility gene Esrrg modulates regulatory T cells through mitochondrial metabolism. Jci Insight. PMID 34156979 DOI: 10.1172/jci.insight.143540 |
0.346 |
|
| 2021 |
Rana J, Perry DJ, Kumar SR, Muñoz-Melero M, Saboungi R, Brusko TM, Biswas M. CAR and TRuC redirected regulatory T cells differ in capacity to control adaptive immunity to FVIII. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 33940160 DOI: 10.1016/j.ymthe.2021.04.034 |
0.324 |
|
| 2021 |
Lin A, Mack JA, Bruggeman B, Jacobsen LM, Posgai AL, Wasserfall CH, Brusko TM, Atkinson MA, Gitelman SE, Gottlieb PA, Gurka MJ, Mathews CE, Schatz DA, Haller MJ. Low-dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report. Diabetes. PMID 33632742 DOI: 10.2337/db20-1103 |
0.444 |
|
| 2021 |
Japp AS, Meng W, Rosenfeld AM, Perry DJ, Thirawatananond P, Bacher RL, Liu C, Gardner JS, Atkinson MA, Kaestner KH, Brusko TM, Naji A, Luning Prak ET, Betts MR. TCR/BCR dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes. Cell. 184: 827-839.e14. PMID 33545036 DOI: 10.1016/j.cell.2020.11.035 |
0.485 |
|
| 2021 |
Ross JJ, Wasserfall CH, Bacher R, Perry DJ, McGrail K, Posgai AL, Dong X, Muir A, Li X, Campbell-Thompson M, Brusko TM, Schatz DA, Haller MJ, Atkinson MA. Exocrine Pancreatic Enzymes Are a Serological Biomarker for Type 1 Diabetes Staging and Pancreas Size. Diabetes. PMID 33441381 DOI: 10.2337/db20-0995 |
0.474 |
|
| 2021 |
Williams MD, Bacher R, Perry DJ, Grace CR, McGrail KM, Posgai AL, Muir A, Chamala S, Haller MJ, Schatz DA, Brusko TM, Atkinson MA, Wasserfall CH. Genetic Composition and Autoantibody Titers Model the Probability of Detecting C-Peptide Following Type 1 Diabetes Diagnosis. Diabetes. PMID 33419759 DOI: 10.2337/db20-0937 |
0.468 |
|
| 2020 |
Walker AF, Atkinson MA, Lee AM, Aulisio G, Brusko TM, Haller MJ, Schatz DA. Teaching Type 1 Diabetes: Creating Stakeholder Engagement in Biomedical Careers Through Undergraduate Research Curriculum. Medical Science Educator. 30: 69-73. PMID 34457640 DOI: 10.1007/s40670-019-00877-0 |
0.379 |
|
| 2020 |
Brusko MA, Stewart JM, Posgai AL, Wasserfall CH, Atkinson MA, Brusko TM, Keselowsky BG. Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype and Inhibits Type 1 Diabetes-Specific Autoreactive T Cell Responses. Frontiers in Immunology. 11: 574447. PMID 33193362 DOI: 10.3389/fimmu.2020.574447 |
0.549 |
|
| 2020 |
Shapiro MR, Yeh WI, Longfield JR, Gallagher J, Infante CM, Wellford S, Posgai AL, Atkinson MA, Campbell-Thompson M, Lieberman SM, Serreze DV, Geurts AM, Chen YG, Brusko TM. CD226 Deletion Reduces Type 1 Diabetes in the NOD Mouse by Impairing Thymocyte Development and Peripheral T Cell Activation. Frontiers in Immunology. 11: 2180. PMID 33013915 DOI: 10.3389/Fimmu.2020.02180 |
0.624 |
|
| 2020 |
Ye C, Low BE, Wiles MV, Brusko TM, Serreze DV, Driver JP. CD70 Inversely Regulates Regulatory T Cells and Invariant NKT Cells and Modulates Type 1 Diabetes in NOD Mice. Journal of Immunology (Baltimore, Md. : 1950). PMID 32868408 DOI: 10.4049/Jimmunol.2000148 |
0.451 |
|
| 2020 |
Jacobsen L, Bundy B, Greco M, Schatz D, Atkinson M, Brusko T, Mathews C, Herold KC, Gitelman S, Krischer J, Haller M. Comparing Beta Cell Preservation Across Clinical Trials in Recent-Onset Type 1 Diabetes. Diabetes Technology & Therapeutics. PMID 32833543 DOI: 10.1089/Dia.2020.0305 |
0.482 |
|
| 2020 |
Carr ALJ, Perry DJ, Lynam AL, Chamala S, Flaxman CS, Sharp SA, Ferrat LA, Jones AG, Beery ML, Jacobsen LM, Wasserfall CH, Campbell-Thompson ML, Kusmartseva I, Posgai A, Schatz DA, ... ... Brusko TM, et al. Histological validation of a type 1 diabetes clinical diagnostic model for classification of diabetes. Diabetic Medicine : a Journal of the British Diabetic Association. PMID 32634859 DOI: 10.1111/Dme.14361 |
0.521 |
|
| 2020 |
Motwani K, Peters LD, Vliegen WH, El-Sayed AG, Seay HR, Lopez MC, Baker HV, Posgai AL, Brusko MA, Perry DJ, Bacher R, Larkin J, Haller MJ, Brusko TM. Human Regulatory T Cells From Umbilical Cord Blood Display Increased Repertoire Diversity and Lineage Stability Relative to Adult Peripheral Blood. Frontiers in Immunology. 11: 611. PMID 32351504 DOI: 10.3389/Fimmu.2020.00611 |
0.464 |
|
| 2020 |
Nelson AS, Maddaloni M, Abbott JR, Hoffman C, Akgul A, Ohland C, Gharaibeh RZ, Jobin C, Brusko TM, Pascual DW. Oral therapy with colonization factor antigen I prevents development of type 1 diabetes in Non-obese Diabetic mice. Scientific Reports. 10: 6156. PMID 32273533 DOI: 10.1038/S41598-020-62881-4 |
0.487 |
|
| 2020 |
Ihantola EL, Ilmonen H, Kailaanmäki A, Rytkönen-Nissinen M, Azam A, Maillère B, Lindestam Arlehamn CS, Sette A, Motwani K, Seay HR, Brusko TM, Knip M, Veijola R, Toppari J, Ilonen J, et al. Characterization of Proinsulin T Cell Epitopes Restricted by Type 1 Diabetes-Associated HLA Class II Molecules. Journal of Immunology (Baltimore, Md. : 1950). PMID 32229538 DOI: 10.4049/Jimmunol.1901079 |
0.438 |
|
| 2020 |
Dean JW, Peters LD, Fuhrman CA, Seay HR, Posgai AL, Stimpson SE, Brusko MA, Perry DJ, Yeh WI, Newby BN, Haller MJ, Muir AB, Atkinson MA, Mathews CE, Brusko TM. Innate inflammation drives NK cell activation to impair Treg activity. Journal of Autoimmunity. 102417. PMID 32035746 DOI: 10.1016/J.Jaut.2020.102417 |
0.573 |
|
| 2020 |
Beam CA, Wasserfall C, Woodwyk A, Akers M, Rauch H, Blok T, Mason P, Vos D, Perry D, Brusko T, Peakman M, Atkinson M. Synchronization of the Normal Human Peripheral Immune System: A Comprehensive Circadian Systems Immunology Analysis. Scientific Reports. 10: 672. PMID 31959869 DOI: 10.1038/S41598-019-56951-5 |
0.533 |
|
| 2020 |
LIN A, PERRY DJ, SCHATZ D, BRUSKO TM, ATKINSON MA, HALLER MJ, MATHEWS CE. 253-OR: Circulating Neutrophil Numbers Increase with Age, but Are Not a Biomarker of T1D Risk Diabetes. 69: 253-OR. DOI: 10.2337/Db20-253-Or |
0.416 |
|
| 2020 |
PETERS LD, POSGAI AL, BRUSKO TM. 1663-P: Gene Editing of the Human T-Cell Receptor Locus Enables Optimized In Vitro Testing of Autoreactive T-Cell Function in Type 1 Diabetes Diabetes. 69: 1663-P. DOI: 10.2337/Db20-1663-P |
0.461 |
|
| 2019 |
Shapiro MR, Wasserfall CH, McGrail SM, Posgai AL, Bacher R, Muir A, Haller MJ, Schatz DA, Wesley JD, von Herrath M, Hagopian WA, Speake C, Atkinson MA, Brusko TM. Insulin-Like Growth Factor Dysregulation Both Preceding and Following Type 1 Diabetes Diagnosis. Diabetes. PMID 31826866 DOI: 10.2337/Db19-0942 |
0.512 |
|
| 2019 |
Battaglia M, Ahmed S, Anderson MS, Atkinson MA, Becker D, Bingley PJ, Bosi E, Brusko TM, DiMeglio LA, Evans-Molina C, Gitelman SE, Greenbaum CJ, Gottlieb PA, Herold KC, Hessner MJ, et al. Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes. Diabetes Care. PMID 31753960 DOI: 10.2337/Dc19-0880 |
0.534 |
|
| 2019 |
Peters L, Posgai A, Brusko TM. Islet-Immune Interactions in Type 1 Diabetes: The Nexus of Beta Cell Destruction. Clinical and Experimental Immunology. PMID 31309537 DOI: 10.1111/Cei.13349 |
0.424 |
|
| 2019 |
Ahmed S, Cerosaletti K, James E, Long SA, Mannering S, Speake C, Nakayama M, Tree T, Roep BO, Herold KC, Brusko TM. Standardizing T-Cell Biomarkers in Type 1 Diabetes: Challenges and Recent Advances. Diabetes. 68: 1366-1379. PMID 31221801 DOI: 10.2337/Db19-0119 |
0.457 |
|
| 2019 |
Titov AA, Baker HV, Brusko TM, Sobel ES, Morel L. Metformin Inhibits the Type 1 IFN Response in Human CD4 T Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 31160534 DOI: 10.4049/Jimmunol.1801651 |
0.464 |
|
| 2019 |
Shapiro MR, Atkinson MA, Brusko TM. Pleiotropic roles of the insulin-like growth factor axis in type 1 diabetes. Current Opinion in Endocrinology, Diabetes, and Obesity. PMID 31145130 DOI: 10.1097/Med.0000000000000484 |
0.504 |
|
| 2019 |
Lewis JS, Stewart JM, Marshall GP, Carstens MR, Zhang Y, Dolgova NV, Xia C, Brusko TM, Wasserfall CH, Clare-Salzler MJ, Atkinson MA, Keselowsky BG. Dual-Sized Microparticle System for Generating Suppressive Dendritic Cells Prevents and Reverses Type 1 Diabetes in the Nonobese Diabetic Mouse Model. Acs Biomaterials Science & Engineering. 5: 2631-2646. PMID 31119191 DOI: 10.1021/Acsbiomaterials.9B00332 |
0.623 |
|
| 2019 |
Khosravi-Maharlooei M, Obradovic A, Misra A, Motwani K, Holzl M, Seay HR, DeWolf S, Nauman G, Danzl N, Li H, Ho SH, Winchester R, Shen Y, Brusko TM, Sykes M. Crossreactive public TCR sequences undergo positive selection in the human thymic repertoire. The Journal of Clinical Investigation. 130. PMID 30920391 DOI: 10.1172/Jci124358 |
0.313 |
|
| 2019 |
Van Gool F, Nguyen MLT, Mumbach MR, Satpathy AT, Rosenthal WL, Giacometti S, Le DT, Liu W, Brusko TM, Anderson MS, Rudensky AY, Marson A, Chang HY, Bluestone JA. A Mutation in the Transcription Factor Foxp3 Drives T Helper 2 Effector Function in Regulatory T Cells. Immunity. PMID 30709738 DOI: 10.1016/J.Immuni.2018.12.016 |
0.574 |
|
| 2019 |
HALLER MJ, GRECO MN, SCHATZ D, ATKINSON MA, BRUSKO TM, MATHEWS CE, JACOBSEN LM, HEROLD KC, GITELMAN SE, KRISCHER J, BUNDY BN. 164-OR: Efficacy of New-Onset Type 1 Diabetes (T1D) Intervention Trials: Variation in 1-Year Outcomes Diabetes. 68: 164-OR. DOI: 10.2337/Db19-164-Or |
0.457 |
|
| 2019 |
Walker AF, Atkinson MA, Lee AM, Aulisio G, Brusko TM, Haller MJ, Schatz DA. Teaching Type 1 Diabetes: Creating Stakeholder Engagement in Biomedical Careers Through Undergraduate Research Curriculum Medical Science Educator. 30: 69-73. DOI: 10.1007/S40670-019-00877-0 |
0.453 |
|
| 2018 |
Marshall GP, Cserny J, Perry DJ, Yeh WI, Seay HR, Elsayed AG, Posgai AL, Brusko TM. Clinical Applications of Regulatory T cells in Adoptive Cell Therapies. Cell & Gene Therapy Insights. 4: 405-429. PMID 34984106 DOI: 10.18609/cgti.2018.042 |
0.308 |
|
| 2018 |
Choi SC, Titov AA, Abboud G, Seay HR, Brusko TM, Roopenian DC, Salek-Ardakani S, Morel L. Inhibition of glucose metabolism selectively targets autoreactive follicular helper T cells. Nature Communications. 9: 4369. PMID 30348969 DOI: 10.1038/S41467-018-06686-0 |
0.417 |
|
| 2018 |
Jacobsen LM, Newby BN, Perry DJ, Posgai AL, Haller MJ, Brusko TM. Immune Mechanisms and Pathways Targeted in Type 1 Diabetes. Current Diabetes Reports. 18: 90. PMID 30168021 DOI: 10.1007/S11892-018-1066-5 |
0.405 |
|
| 2018 |
Perry DJ, Wasserfall CH, Oram RA, Williams MD, Posgai A, Muir AB, Haller MJ, Schatz DA, Wallet MA, Mathews CE, Atkinson MA, Brusko TM. Application of a Genetic Risk Score to Racially Diverse Type 1 Diabetes Populations Demonstrates the Need for Diversity in Risk-Modeling. Scientific Reports. 8: 4529. PMID 29540798 DOI: 10.1038/S41598-018-22574-5 |
0.479 |
|
| 2018 |
YEH W, SEAY H, MATHEWS CE, BRUSKO TM. Costimulatory Molecules CD226 and TIGIT Impact CD8+ T-Cell Activity and Function during Type 1 Diabetes Diabetes. 67: 96-OR. DOI: 10.2337/Db18-96-Or |
0.463 |
|
| 2018 |
CAMARGO A, PERRY DJ, BRUSKO TM, WALLET MA. SH2B3 (lnk) Regulates Type 1 Diabetes Immune Phenotypes Diabetes. 67: 224-LB. DOI: 10.2337/Db18-224-Lb |
0.421 |
|
| 2018 |
SHAPIRO M, WASSERFALL C, SCHULTZ AR, MCGRAIL SM, HALLER MJ, SCHATZ D, ATKINSON MA, BRUSKO TM. Insulin-Like Growth-Factor Axis Collectively Identifies Pre–Type 1 Diabetes Diabetes. 67: 1967-P. DOI: 10.2337/Db18-1967-P |
0.485 |
|
| 2018 |
ROSS JJ, WASSERFALL C, PERRY DJ, MCGRAIL KM, POSGAI AL, BRUSKO TM, SCHATZ D, HALLER MJ, ATKINSON MA. Exocrine Pancreatic Function as a Novel Biomarker in Pre-T1D Diabetes. 67: 1543-P. DOI: 10.2337/Db18-1543-P |
0.515 |
|
| 2017 |
Fuchs A, Gliwiński M, Grageda N, Spiering R, Abbas AK, Appel S, Bacchetta R, Battaglia M, Berglund D, Blazar B, Bluestone JA, Bornhäuser M, Ten Brinke A, Brusko TM, Cools N, et al. Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization. Frontiers in Immunology. 8: 1844. PMID 29379498 DOI: 10.3389/Fimmu.2017.01844 |
0.574 |
|
| 2017 |
Yeh WI, Seay HR, Newby B, Posgai AL, Moniz FB, Michels A, Mathews CE, Bluestone JA, Brusko TM. Avidity and Bystander Suppressive Capacity of Human Regulatory T Cells Expressing De Novo Autoreactive T-Cell Receptors in Type 1 Diabetes. Frontiers in Immunology. 8: 1313. PMID 29123516 DOI: 10.3389/Fimmu.2017.01313 |
0.634 |
|
| 2017 |
Wallet MA, Santostefano KE, Terada N, Brusko TM. Isogenic Cellular Systems Model the Impact of Genetic Risk Variants in the Pathogenesis of Type 1 Diabetes. Frontiers in Endocrinology. 8: 276. PMID 29093700 DOI: 10.3389/Fendo.2017.00276 |
0.379 |
|
| 2017 |
Jacobsen LM, Posgai A, Seay HR, Haller MJ, Brusko TM. T Cell Receptor Profiling in Type 1 Diabetes. Current Diabetes Reports. 17: 118. PMID 29022222 DOI: 10.1007/S11892-017-0946-4 |
0.501 |
|
| 2017 |
Chen J, Chernatynskaya AV, Li JW, Kimbrell MR, Cassidy RJ, Perry DJ, Muir AB, Atkinson MA, Brusko TM, Mathews CE. T cells display mitochondria hyperpolarization in human type 1 diabetes. Scientific Reports. 7: 10835. PMID 28883439 DOI: 10.1038/S41598-017-11056-9 |
0.609 |
|
| 2017 |
Newby BN, Brusko TM, Zou B, Atkinson MA, Clare-Salzler M, Mathews CE. Type 1 Interferons Potentiate Human CD8(+) T Cell Cytotoxicity Through a STAT4 and Granzyme B Dependent Pathway. Diabetes. PMID 28877912 DOI: 10.2337/Db17-0106 |
0.621 |
|
| 2017 |
Sebastiani G, Ventriglia G, Stabilini A, Socci C, Morsiani C, Laurenzi A, Nigi L, Formichi C, Mfarrej B, Petrelli A, Fousteri G, Brusko TM, Dotta F, Battaglia M. Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression. Scientific Reports. 7: 6897. PMID 28761107 DOI: 10.1038/S41598-017-07172-1 |
0.384 |
|
| 2017 |
Marcial GE, Ford AL, Haller MJ, Gezan SA, Harrison NA, Cai D, Meyer JL, Perry DJ, Atkinson MA, Wasserfall CH, Garrett T, Gonzalez CF, Brusko TM, Dahl WJ, Lorca GL. Lactobacillus johnsonii N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy Adults. Frontiers in Immunology. 8: 655. PMID 28659913 DOI: 10.3389/Fimmu.2017.00655 |
0.518 |
|
| 2017 |
Seay HR, Putnam AL, Cserny J, Posgai AL, Rosenau EH, Wingard JR, Girard KF, Kraus M, Lares AP, Brown HL, Brown KS, Balavage KT, Peters LD, Bushdorf AN, Atkinson MA, ... ... Brusko TM, et al. Expansion of Human Tregs from Cryopreserved Umbilical Cord Blood for GMP-Compliant Autologous Adoptive Cell Transfer Therapy. Molecular Therapy. Methods & Clinical Development. 4: 178-191. PMID 28345003 DOI: 10.1016/J.Omtm.2016.12.003 |
0.655 |
|
| 2017 |
Li X, Campbell-Thompson M, Wasserfall CH, McGrail K, Posgai A, Schultz AR, Brusko TM, Shuster J, Liang F, Muir A, Schatz D, Haller MJ, Atkinson MA. Serum Trypsinogen Levels in Type 1 Diabetes. Diabetes Care. PMID 28115475 DOI: 10.2337/Dc16-1774 |
0.535 |
|
| 2017 |
Lin A, Mathews C, Haller M, Brusko T, Atkinson M, Flynn R. 2431 Journal of Clinical and Translational Science. 1: 37-37. DOI: 10.1017/cts.2017.136 |
0.439 |
|
| 2016 |
Seay HR, Yusko E, Rothweiler SJ, Zhang L, Posgai AL, Campbell-Thompson M, Vignali M, Emerson RO, Kaddis JS, Ko D, Nakayama M, Smith MJ, Cambier JC, Pugliese A, Atkinson MA, ... ... Brusko TM, et al. Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes. Jci Insight. 1: e88242. PMID 27942583 DOI: 10.1172/Jci.Insight.88242 |
0.6 |
|
| 2016 |
Driver JP, Racine JJ, Ye C, Lamont DJ, Newby BN, McPhee-Leeth CG, Chapman HD, Brusko TM, Chen YG, Mathews CE, Serreze DV. Interferon gamma Limits Diabetogenic CD8 T-Cell Effector Responses in Type-1 Diabetes. Diabetes. PMID 27920091 DOI: 10.2337/Db16-0846 |
0.542 |
|
| 2016 |
Delitto D, Delitto AE, DiVita BB, Pham K, Han S, Hartlage ER, Newby BN, Gerber MH, Behrns KE, Moldawer LL, Thomas RM, George T, Brusko T, Mathews CE, Liu C, et al. Human pancreatic cancer cells induce a MyD88-dependent stromal response to promote a tumor-tolerant immune microenvironment. Cancer Research. PMID 27864347 DOI: 10.1158/0008-5472.Can-16-1765 |
0.404 |
|
| 2016 |
Haller MJ, Gitelman SE, Gottlieb PA, Michels AW, Perry DJ, Schultz AR, Hulme MA, Shuster JJ, Zou B, Wasserfall CH, Posgai A, Mathews CE, Brusko TM, Atkinson MA, Schatz DA. Anti-Thymocyte Globulin + G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders with Established Type 1 Diabetes. Diabetes. PMID 27669730 DOI: 10.2337/Db16-0823 |
0.575 |
|
| 2016 |
Choi SC, Hutchinson TE, Titov AA, Seay HR, Li S, Brusko TM, Croker BP, Salek-Ardakani S, Morel L. The Lupus Susceptibility Gene Pbx1 Regulates the Balance between Follicular Helper T Cell and Regulatory T Cell Differentiation. Journal of Immunology (Baltimore, Md. : 1950). PMID 27296664 DOI: 10.4049/Jimmunol.1502283 |
0.457 |
|
| 2016 |
Choi S, Titov AA, Yin Y, Croker BP, Sobel ES, Roopenian DC, Brusko TM, Morel L. AI-25 Glucose oxidation in lupus T cells Lupus Science & Medicine. 3. DOI: 10.1136/Lupus-2016-000179.25 |
0.469 |
|
| 2015 |
Haller MJ, Atkinson MA, Wasserfall CH, Brusko TM, Mathews CE, Hulme M, Cintron M, Shuster J, McGrail K, Posgai A, Schatz D. Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetes. Clinical and Experimental Immunology. PMID 26462724 DOI: 10.1111/Cei.12731 |
0.58 |
|
| 2015 |
Xue S, Posgai A, Wasserfall C, Myhr C, Campbell-Thompson M, Mathews CE, Brusko T, Rabinovitch A, Savinov A, Battaglia M, Schatz D, Haller M, Atkinson M. Combination therapy reverses hyperglycemia in NOD mice with established type 1 diabetes. Diabetes. PMID 26185279 DOI: 10.2337/Db15-0164 |
0.573 |
|
| 2015 |
Fuhrman CA, Yeh WI, Seay HR, Saikumar Lakshmi P, Chopra G, Zhang L, Perry DJ, McClymont SA, Yadav M, Lopez MC, Baker HV, Zhang Y, Li Y, Whitley M, von Schack D, ... ... Brusko TM, et al. Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226. Journal of Immunology (Baltimore, Md. : 1950). 195: 145-55. PMID 25994968 DOI: 10.4049/Jimmunol.1402381 |
0.752 |
|
| 2015 |
Yin Y, Choi SC, Xu Z, Perry DJ, Seay H, Croker BP, Sobel ES, Brusko TM, Morel L. Normalization of CD4+ T cell metabolism reverses lupus. Science Translational Medicine. 7: 274ra18. PMID 25673763 DOI: 10.1126/Scitranslmed.Aaa0835 |
0.427 |
|
| 2015 |
Haller MJ, Gitelman SE, Gottlieb PA, Michels AW, Rosenthal SM, Shuster JJ, Zou B, Brusko TM, Hulme MA, Wasserfall CH, Mathews CE, Atkinson MA, Schatz DA. Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes. The Journal of Clinical Investigation. 125: 448-55. PMID 25500887 DOI: 10.1172/Jci78492 |
0.535 |
|
| 2015 |
Fuhrman CA, Yeh WI, Seay HR, Lakshmi PS, Chopra G, Zhang L, Perry DJ, McClymont SA, Yadav M, Lopez MC, Baker HV, Zhang Y, Li Y, Whitley M, Von Schack D, ... ... Brusko TM, et al. Divergent phenotypes of human regulatory T cells expressing the receptors TIGIT and CD226 Journal of Immunology. 195: 145-155. DOI: 10.4049/jimmunol.1402381 |
0.686 |
|
| 2014 |
Sarkar D, Biswas M, Liao G, Seay HR, Perrin GQ, Markusic DM, Hoffman BE, Brusko TM, Terhorst C, Herzog RW. Ex Vivo Expanded Autologous Polyclonal Regulatory T Cells Suppress Inhibitor Formation in Hemophilia. Molecular Therapy. Methods & Clinical Development. 1. PMID 25364772 DOI: 10.1038/Mtm.2014.30 |
0.441 |
|
| 2014 |
Lewis JS, Roche C, Zhang Y, Brusko TM, Wasserfall CH, Atkinson M, Clare-Salzler MJ, Keselowsky BG. Combinatorial delivery of immunosuppressive factors to dendritic cells using dual-sized microspheres. Journal of Materials Chemistry. B, Materials For Biology and Medicine. 2: 2562-2574. PMID 24778809 DOI: 10.1039/C3Tb21460E |
0.529 |
|
| 2013 |
Gjymishka A, Coman RM, Brusko TM, Glover SC. Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes. Immunotherapy. 5: 1357-66. PMID 24283846 DOI: 10.2217/Imt.13.130 |
0.341 |
|
| 2013 |
Mueller C, Chulay JD, Trapnell BC, Humphries M, Carey B, Sandhaus RA, McElvaney NG, Messina L, Tang Q, Rouhani FN, Campbell-Thompson M, Fu AD, Yachnis A, Knop DR, Ye GJ, ... ... Brusko TM, et al. Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression. The Journal of Clinical Investigation. 123: 5310-8. PMID 24231351 DOI: 10.1172/Jci70314 |
0.366 |
|
| 2013 |
Myhr CB, Hulme MA, Wasserfall CH, Hong PJ, Lakshmi PS, Schatz DA, Haller MJ, Brusko TM, Atkinson MA. The autoimmune disease-associated SNP rs917997 of IL18RAP controls IFNγ production by PBMC. Journal of Autoimmunity. 44: 8-12. PMID 23891168 DOI: 10.1016/J.Jaut.2013.06.001 |
0.51 |
|
| 2013 |
Haller MJ, Wasserfall CH, Hulme MA, Cintron M, Brusko TM, McGrail KM, Wingard JR, Theriaque DW, Shuster JJ, Ferguson RJ, Kozuch M, Clare-Salzler M, Atkinson MA, Schatz DA. Autologous umbilical cord blood infusion followed by oral docosahexaenoic acid and vitamin D supplementation for C-peptide preservation in children with Type 1 diabetes. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1126-9. PMID 23611977 DOI: 10.1016/J.Bbmt.2013.04.011 |
0.528 |
|
| 2013 |
Cabrera R, Ararat M, Xu Y, Brusko T, Wasserfall C, Atkinson MA, Chang LJ, Liu C, Nelson DR. Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma. Cancer Immunology, Immunotherapy : Cii. 62: 737-46. PMID 23223899 DOI: 10.1007/S00262-012-1380-8 |
0.572 |
|
| 2012 |
Cabrera R, Fitian AI, Ararat M, Xu Y, Brusko T, Wasserfall C, Atkinson MA, Liu C, Nelson DR. Serum levels of soluble CD25 as a marker for hepatocellular carcinoma. Oncology Letters. 4: 840-846. PMID 23205111 DOI: 10.3892/Ol.2012.826 |
0.423 |
|
| 2012 |
Thompson JA, Perry D, Brusko TM. Autologous regulatory T cells for the treatment of type 1 diabetes. Current Diabetes Reports. 12: 623-32. PMID 22843491 DOI: 10.1007/S11892-012-0304-5 |
0.479 |
|
| 2012 |
Hulme MA, Wasserfall CH, Atkinson MA, Brusko TM. Central role for interleukin-2 in type 1 diabetes. Diabetes. 61: 14-22. PMID 22187370 DOI: 10.2337/Db11-1213 |
0.582 |
|
| 2012 |
Sarkar D, Markusic DM, Terhorst C, Brusko T, Herzog RW. Suppression of Inhibitor Formation in Protein and Gene Therapy for Hemophilia Using Ex Vivo Expanded Treg Blood. 120: 13-13. DOI: 10.1182/Blood.V120.21.13.13 |
0.375 |
|
| 2011 |
Ararat MA, Fitian AI, Brusko T, Xu Y, Wasserfall C, Atkinson M, Liu C, Allegra CJ, Nelson D, Cabrera R. The soluble form of the IL-2 receptor (sCD25) as a novel biomarker for hepatocellular carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e14629. PMID 28021352 DOI: 10.1200/Jco.2011.29.15_Suppl.E14629 |
0.432 |
|
| 2011 |
Haller MJ, Wasserfall CH, Hulme MA, Cintron M, Brusko TM, McGrail KM, Sumrall TM, Wingard JR, Theriaque DW, Shuster JJ, Atkinson MA, Schatz DA. Autologous umbilical cord blood transfusion in young children with type 1 diabetes fails to preserve C-peptide. Diabetes Care. 34: 2567-9. PMID 22011412 DOI: 10.2337/Dc11-1406 |
0.504 |
|
| 2011 |
Sobel ES, Brusko TM, Butfiloski EJ, Hou W, Li S, Cuda CM, Abid AN, Reeves WH, Morel L. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus. Arthritis Research & Therapy. 13: R106. PMID 21708033 DOI: 10.1186/Ar3387 |
0.43 |
|
| 2011 |
McClymont SA, Putnam AL, Lee MR, Esensten JH, Liu W, Hulme MA, Hoffmüller U, Baron U, Olek S, Bluestone JA, Brusko TM. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. Journal of Immunology (Baltimore, Md. : 1950). 186: 3918-26. PMID 21368230 DOI: 10.4049/Jimmunol.1003099 |
0.641 |
|
| 2011 |
Golovina TN, Mikheeva T, Brusko TM, Blazar BR, Bluestone JA, Riley JL. Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells. Plos One. 6: e15868. PMID 21253593 DOI: 10.1371/Journal.Pone.0015868 |
0.593 |
|
| 2011 |
Cabrera R, Ararat M, Cao M, Xu Y, Wasserfall C, Brusko T, Atkinson MA, Liu C, Nelson DR. Abstract 2702: Sorafenib modulates immune responses in patients with hepatocellular carcinoma Cancer Research. 71: 2702-2702. DOI: 10.1158/1538-7445.Am2011-2702 |
0.521 |
|
| 2010 |
Brusko TM, Koya RC, Zhu S, Lee MR, Putnam AL, McClymont SA, Nishimura MI, Han S, Chang LJ, Atkinson MA, Ribas A, Bluestone JA. Human antigen-specific regulatory T cells generated by T cell receptor gene transfer. Plos One. 5: e11726. PMID 20668510 DOI: 10.1371/Journal.Pone.0011726 |
0.669 |
|
| 2010 |
Brusko T, Koya R, Zhu S, Lee M, Putnam A, McClymont S, Nishimura M, Xia N, Bluestone J. Lentiviral TCR-engineered Tregs Demonstrate Effective Suppression of T Cell Responses Clinical Immunology. 135: S30. DOI: 10.1016/J.Clim.2010.03.093 |
0.547 |
|
| 2010 |
Putnam A, Lee M, Liu W, Escosa H, Brusko T, Bluestone J. The Use of CD4+CD127lo/-CD25+ Polyclonal Tregs for the Treatment of Recent Onset T1D in a Phase I Clinical Trial Clinical Immunology. 135: S23. DOI: 10.1016/J.Clim.2010.03.073 |
0.524 |
|
| 2010 |
McClymont S, Putnam A, Lee M, Esensten J, Liu W, Olek S, Baron U, Hoffmuller U, Bluestone J, Brusko T. Plasticity of Human Regulatory T Cells - Characterization of IFN-γ-Producing Cells Clinical Immunology. 135: S5-S6. DOI: 10.1016/J.Clim.2010.03.023 |
0.564 |
|
| 2009 |
Brusko TM, Wasserfall CH, Hulme MA, Cabrera R, Schatz D, Atkinson MA. Influence of membrane CD25 stability on T lymphocyte activity: implications for immunoregulation. Plos One. 4: e7980. PMID 19956753 DOI: 10.1371/Journal.Pone.0007980 |
0.58 |
|
| 2009 |
Brusko TM, Bluestone JA. Regulatory T cells directed to the site of the action. Proceedings of the National Academy of Sciences of the United States of America. 106: 20553-4. PMID 19955436 DOI: 10.1073/Pnas.0911848107 |
0.566 |
|
| 2009 |
Haller MJ, Wasserfall CH, McGrail KM, Cintron M, Brusko TM, Wingard JR, Kelly SS, Shuster JJ, Atkinson MA, Schatz DA. Autologous umbilical cord blood transfusion in very young children with type 1 diabetes. Diabetes Care. 32: 2041-6. PMID 19875605 DOI: 10.2337/Dc09-0967 |
0.5 |
|
| 2009 |
Brusko TM. Mesenchymal stem cells: a potential border patrol for transplanted islets? Diabetes. 58: 1728-9. PMID 19638531 DOI: 10.2337/Db09-0749 |
0.396 |
|
| 2009 |
Putnam AL, Brusko TM, Lee MR, Liu W, Szot GL, Ghosh T, Atkinson MA, Bluestone JA. Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes. 58: 652-62. PMID 19074986 DOI: 10.2337/Db08-1168 |
0.685 |
|
| 2009 |
Putnam A, McClymont S, Brusko T, Lee M, Liu W, Ghosh T, Bluestone J. T.115. Stability and Purity of Expanded Human CD4+CD127lo/-CD25+Tregs for Use in Cellular Therapy for the Treatment of Type 1 Diabetes Clinical Immunology. 131: S84-S85. DOI: 10.1016/J.Clim.2009.03.248 |
0.609 |
|
| 2009 |
Brusko T, Zhu S, Putnam A, Lee M, McClymont S, Liu W, Nishimura M, Koya R, Tree T, Riley J, Bluestone J. OR.105. Development of Engineered Antigen-specific Human Regulatory T Cells for the Treatment of Type 1 Diabetes by TCR Gene Transfer Clinical Immunology. 131: S42-S43. DOI: 10.1016/J.Clim.2009.03.120 |
0.598 |
|
| 2008 |
Xue S, Wasserfall CH, Parker M, Brusko TM, McGrail S, McGrail K, Moore M, Campbell-Thompson M, Schatz DA, Atkinson MA, Haller MJ. Exendin-4 therapy in NOD mice with new-onset diabetes increases regulatory T cell frequency. Annals of the New York Academy of Sciences. 1150: 152-6. PMID 19120286 DOI: 10.1196/Annals.1447.049 |
0.59 |
|
| 2008 |
Stalvey MS, Brusko TM, Mueller C, Wasserfall CH, Schatz DA, Atkinson MA, Flotte TR. CFTR mutations impart elevated immune reactivity in a murine model of cystic fibrosis related diabetes. Cytokine. 44: 154-9. PMID 18778952 DOI: 10.1016/J.Cyto.2008.07.468 |
0.488 |
|
| 2008 |
Brusko TM, Putnam AL, Bluestone JA. Human regulatory T cells: role in autoimmune disease and therapeutic opportunities. Immunological Reviews. 223: 371-90. PMID 18613848 DOI: 10.1111/J.1600-065X.2008.00637.X |
0.564 |
|
| 2008 |
George JF, Braun A, Brusko TM, Joseph R, Bolisetty S, Wasserfall CH, Atkinson MA, Agarwal A, Kapturczak MH. Suppression by CD4+CD25+ regulatory T cells is dependent on expression of heme oxygenase-1 in antigen-presenting cells. The American Journal of Pathology. 173: 154-60. PMID 18511516 DOI: 10.2353/Ajpath.2008.070963 |
0.589 |
|
| 2008 |
Brusko T, Bluestone J. Clinical application of regulatory T cells for treatment of type 1 diabetes and transplantation. European Journal of Immunology. 38: 931-4. PMID 18395864 DOI: 10.1002/Eji.200738108 |
0.589 |
|
| 2008 |
Haller MJ, Viener HL, Wasserfall C, Brusko T, Atkinson MA, Schatz DA. Autologous umbilical cord blood infusion for type 1 diabetes. Experimental Hematology. 36: 710-5. PMID 18358588 DOI: 10.1016/J.Exphem.2008.01.009 |
0.517 |
|
| 2008 |
Simon G, Parker M, Ramiya V, Wasserfall C, Huang Y, Bresson D, Schwartz RF, Campbell-Thompson M, Tenace L, Brusko T, Xue S, Scaria A, Lukason M, Eisenbeis S, Williams J, et al. Murine antithymocyte globulin therapy alters disease progression in NOD mice by a time-dependent induction of immunoregulation. Diabetes. 57: 405-14. PMID 18039815 DOI: 10.2337/Db06-1384 |
0.532 |
|
| 2007 |
Brusko TM, Hulme MA, Myhr CB, Haller MJ, Atkinson MA. Assessing the in vitro suppressive capacity of regulatory T cells. Immunological Investigations. 36: 607-28. PMID 18161521 DOI: 10.1080/08820130701790368 |
0.555 |
|
| 2007 |
Brusko T, Atkinson M. Treg in type 1 diabetes. Cell Biochemistry and Biophysics. 48: 165-75. PMID 17709886 DOI: 10.1007/S12013-007-0018-5 |
0.615 |
|
| 2007 |
Lowe CE, Cooper JD, Brusko T, Walker NM, Smyth DJ, Bailey R, Bourget K, Plagnol V, Field S, Atkinson M, Clayton DG, Wicker LS, Todd JA. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nature Genetics. 39: 1074-82. PMID 17676041 DOI: 10.1038/Ng2102 |
0.498 |
|
| 2007 |
Brusko T, Wasserfall C, McGrail K, Schatz R, Viener HL, Schatz D, Haller M, Rockell J, Gottlieb P, Clare-Salzler M, Atkinson M. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes. Diabetes. 56: 604-12. PMID 17327427 DOI: 10.2337/Db06-1248 |
0.595 |
|
| 2007 |
Brusko T, Wasserfall C, McGrail K, Moore M, Huegel A, Schatz D, Atkinson M. Regulatory T Cells Require Serum for Suppression of Effector T Cell Proliferation and Express Stable Membrane-bound CD25 Clinical Immunology. 123: S4. DOI: 10.1016/J.Clim.2007.03.183 |
0.573 |
|
| 2006 |
Scumpia PO, Delano MJ, Kelly KM, O'Malley KA, Efron PA, McAuliffe PF, Brusko T, Ungaro R, Barker T, Wynn JL, Atkinson MA, Reeves WH, Salzler MJ, Moldawer LL. Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. Journal of Immunology (Baltimore, Md. : 1950). 177: 7943-9. PMID 17114466 DOI: 10.4049/Jimmunol.177.11.7943 |
0.584 |
|
| 2006 |
Araya CE, Wasserfall CH, Brusko TM, Mu W, Segal MS, Johnson RJ, Garin EH. A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome. Pediatric Nephrology (Berlin, Germany). 21: 603-10. PMID 16525836 DOI: 10.1007/S00467-006-0026-5 |
0.372 |
|
| 2006 |
Burkhardt BR, Greene SR, White P, Wong RK, Brestelli JE, Yang J, Robert CE, Brusko TM, Wasserfall CH, Wu J, Atkinson MA, Gao Z, Kaestner KH, Wolf BA. PANDER-induced cell-death genetic networks in islets reveal central role for caspase-3 and cyclin-dependent kinase inhibitor 1A (p21). Gene. 369: 134-41. PMID 16412588 DOI: 10.1016/J.Gene.2005.10.040 |
0.473 |
|
| 2005 |
Brusko TM, Wasserfall CH, Clare-Salzler MJ, Schatz DA, Atkinson MA. Functional defects and the influence of age on the frequency of CD4 +CD25+ T-cells in type 1 diabetes Diabetes. 54: 1407-1414. PMID 15855327 DOI: 10.2337/Diabetes.54.5.1407 |
0.629 |
|
| 2005 |
Brusko TM, Wasserfall CH, Agarwal A, Kapturczak MH, Atkinson MA. An integral role for heme oxygenase-1 and carbon monoxide in maintaining peripheral tolerance by CD4+CD25+ regulatory T cells. Journal of Immunology (Baltimore, Md. : 1950). 174: 5181-6. PMID 15843512 DOI: 10.4049/Jimmunol.174.9.5181 |
0.575 |
|
| 2005 |
Morales A, Wasserfall C, Brusko T, Carter C, Schatz D, Silverstein J, Ellis T, Atkinson M. Adiponectin and leptin concentrations may aid in discriminating disease forms in children and adolescents with type 1 and type 2 diabetes. Diabetes Care. 27: 2010-4. PMID 15277432 DOI: 10.2337/Diacare.27.8.2010 |
0.533 |
|
| 2004 |
Haller MJ, Samyn M, Nichols WW, Brusko T, Wasserfall C, Schwartz RF, Atkinson M, Shuster JJ, Pierce GL, Silverstein JH. Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetes Diabetes Care. 27: 2911-2917. PMID 15562206 DOI: 10.2337/Diacare.27.12.2911 |
0.494 |
|
| 2004 |
You S, Chen C, Lee WH, Brusko T, Atkinson M, Liu CP. Presence of diabetes-inhibiting, glutamic acid decarboxylase-specific, IL-10-dependent, regulatory T cells in naive nonobese diabetic mice. Journal of Immunology (Baltimore, Md. : 1950). 173: 6777-85. PMID 15557171 DOI: 10.4049/Jimmunol.173.11.6777 |
0.597 |
|
| 2004 |
Kapturczak MH, Wasserfall C, Brusko T, Campbell-Thompson M, Ellis TM, Atkinson MA, Agarwal A. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. The American Journal of Pathology. 165: 1045-53. PMID 15331427 DOI: 10.1016/S0002-9440(10)63365-2 |
0.5 |
|
| 2004 |
Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D, Zheng W, Purohit S, Podolsky RH, Muir A, Wang J, Dong Z, Brusko T, Atkinson M, Pozzilli P, et al. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nature Genetics. 36: 837-41. PMID 15247916 DOI: 10.1038/Ng1391 |
0.483 |
|
| 2004 |
Zhang YC, Powers M, Wasserfall C, Brusko T, Song S, Flotte T, Snyder RO, Potter M, Scott-Jorgensen M, Campbell-Thompson M, Crawford JM, Nick HS, Agarwal A, Ellis TM, Atkinson MA. Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunity. Gene Therapy. 11: 233-40. PMID 14737082 DOI: 10.1038/Sj.Gt.3302144 |
0.485 |
|
| 2004 |
Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D, Zheng W, Purohit S, Podolsky RH, Muir A, Wang J, Dong Z, Brusko T, Atkinson M, Pozzilli P, et al. Erratum: Corrigendum: A functional variant of SUMO4, a new IκBα modifier, is associated with type 1 diabetes Nature Genetics. 36: 1024-1024. DOI: 10.1038/Ng0904-1024B |
0.486 |
|
| 2003 |
Goudy KS, Burkhardt BR, Wasserfall C, Song S, Campbell-Thompson ML, Brusko T, Powers MA, Clare-Salzler MJ, Sobel ES, Ellis TM, Flotte TR, Atkinson MA. Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion. Journal of Immunology (Baltimore, Md. : 1950). 171: 2270-8. PMID 12928371 DOI: 10.4049/Jimmunol.171.5.2270 |
0.59 |
|
| 2003 |
Zhang YC, Pileggi A, Agarwal A, Molano RD, Powers M, Brusko T, Wasserfall C, Goudy K, Zahr E, Poggioli R, Scott-Jorgensen M, Campbell-Thompson M, Crawford JM, Nick H, Flotte T, et al. Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice. Diabetes. 52: 708-16. PMID 12606512 DOI: 10.2337/Diabetes.52.3.708 |
0.526 |
|
| Show low-probability matches. |